Clinica DE Las Varices Y Laser is categorized under Nonclassified Establishments in Irving, TX and active since 2008.
Clinica DE Las Varices Y Laser was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Nonclassified Establishments business, which does work in the BOTH market, and is classified as a Nonclassified Establishments, under code number 8121120 by the NAICS.
If you are seeking more information, feel free to contact Leslie Argueta at the company’s single location by writing to 613 North O Connor Road, Irving, Texas TX 75061 or by phoning (214) 441-0064. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinica DE Las Varices Y Laser |
| Contact Person: | Leslie Argueta |
| Address: | 613 North O Connor Road, Irving, Texas 75061 |
| Phone Number: | (214) 441-0064 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Nonclassified Establishments |
| SIC Code: | 9999 |
| NAICS Code: | 8121120 |
| Share This Business: |
Clinica DE Las Varices Y Laser was started in 2008 to provide professional Nonclassified Establishments under the SIC code 9999 and NAICS code 8121120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Leslie Argueta for inquiries that concern Clinica DE Las Varices Y Laser by calling the company number (214) 441-0064, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinica DE Las Varices Y Laser can be found at the coordinates 32.82067,-96.94965 as well as the street address 613 North O Connor Road in Irving, Texas 75061.
For its online presence, you may visit Clinica DE Las Varices Y Laser’s website at and engage with its social media outlets through on Twitter and on Facebook.